WO2013121334A3 - Agents for treating neurodegenerative disorders - Google Patents

Agents for treating neurodegenerative disorders Download PDF

Info

Publication number
WO2013121334A3
WO2013121334A3 PCT/IB2013/051072 IB2013051072W WO2013121334A3 WO 2013121334 A3 WO2013121334 A3 WO 2013121334A3 IB 2013051072 W IB2013051072 W IB 2013051072W WO 2013121334 A3 WO2013121334 A3 WO 2013121334A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
agents
neurodegenerative disorders
treating neurodegenerative
neurological disorders
Prior art date
Application number
PCT/IB2013/051072
Other languages
French (fr)
Other versions
WO2013121334A2 (en
Inventor
Nina N. MAKHOVA
Vera Y. PETUKHOVA
Alexander V. SHEVTSOV
Vladimir V. NOVAKOVSKIY
Vladimir Vladimirovich KUZNETSOV
Original Assignee
Cro Consulting Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cro Consulting Limited filed Critical Cro Consulting Limited
Priority to JP2014557140A priority Critical patent/JP2015512874A/en
Publication of WO2013121334A2 publication Critical patent/WO2013121334A2/en
Publication of WO2013121334A3 publication Critical patent/WO2013121334A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D229/00—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • C07D229/02—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms containing three-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

The present invention relates to compounds of formula I, use of these compounds to treat mental and neurological disorders, especially depressions and psychoses of different etiology and methods for their preparation. The compounds provided for the treatment of mental and neurological disorders are presented by a general formula I wherein R, R', R", R'" are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds.
PCT/IB2013/051072 2012-02-17 2013-02-08 Agents for treating neurodegenerative disorders WO2013121334A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014557140A JP2015512874A (en) 2012-02-17 2013-02-08 Neurodegenerative disorder treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600037P 2012-02-17 2012-02-17
US61/600,037 2012-02-17

Publications (2)

Publication Number Publication Date
WO2013121334A2 WO2013121334A2 (en) 2013-08-22
WO2013121334A3 true WO2013121334A3 (en) 2013-10-31

Family

ID=48577154

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/051072 WO2013121334A2 (en) 2012-02-17 2013-02-08 Agents for treating neurodegenerative disorders

Country Status (2)

Country Link
JP (1) JP2015512874A (en)
WO (1) WO2013121334A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1136343B (en) * 1961-01-10 1962-09-13 Bergwerksverband Gmbh Process for the preparation of C, C-dialkyl-N, N'-diacetyl-diaza-cyclopropanes
GB1081292A (en) * 1963-09-18 1967-08-31 Whiffen & Sons Ltd Isohydrazone derivatives
GB1187393A (en) * 1966-07-13 1970-04-08 Novo Terapeutisk Labor As Improvements in or relating to Piperidine Compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1136343B (en) * 1961-01-10 1962-09-13 Bergwerksverband Gmbh Process for the preparation of C, C-dialkyl-N, N'-diacetyl-diaza-cyclopropanes
GB1081292A (en) * 1963-09-18 1967-08-31 Whiffen & Sons Ltd Isohydrazone derivatives
GB1187393A (en) * 1966-07-13 1970-04-08 Novo Terapeutisk Labor As Improvements in or relating to Piperidine Compounds

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KOSTYANOVSKII, R. G. ET AL: "Synthesis and psychotropic activity of functional substituted diaziridines and bisdiaziridines", XP002701577, retrieved from STN Database accession no. 1987:27665 *
ISAEV S D ET AL: "Acyl and carbamoyl derivatives of adamantane-2-spiroaziridine, -diaziridine, and -oxaziridine", ZHURNAL ORGANICHESKOI KHIMII, MAIK NAUKA, MOSCOW, RU, vol. 24, no. 12, 1 January 1988 (1988-01-01), pages 2611 - 2617, XP009171033, ISSN: 0514-7492 *
KOSTYANOVSKII R G ET AL: "Synthesis and psychotropic activity of functional substituted diaziridines and bisdiaziridines", KHIMIKO-FARMATSEVTICHESKII ZHURNAL, MOSCOW, RU, vol. 20, no. 6, 1 January 1986 (1986-01-01), pages 671 - 674, XP009154974, ISSN: 0023-1134 *
KOSTYANOVSKY ET AL: "1,2-Di-tert-butyldiaziridine", MENDELEEV COMMUNICATIONS, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 6, no. 3, 1 January 1996 (1996-01-01), pages 106 - 107, XP022529385, ISSN: 0959-9436, DOI: 10.1070/MC1996V006N03ABEH000601 *
MAKHOVA ET AL: "Effective synthesis of 1,2-di-, 1,2,3-tri-, 1,2,3,3-tetraalkyldiaziridines and 1,5-diazabicyclo[3.1.0]hexanes", MENDELEEV COMMUNICATIONS, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 10, no. 5, 1 January 2000 (2000-01-01), pages 182 - 184, XP022529242, ISSN: 0959-9436, DOI: 10.1070/MC2000V010N05ABEH001350 *
MAKHOVA ET AL: "N-Alkylation of diaziridines", MENDELEEV COMMUNICATIONS, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 9, no. 3, 1 January 1999 (1999-01-01), pages 112 - 114, XP022529571, ISSN: 0959-9436, DOI: 10.1070/MC1999V009N03ABEH001121 *
NABIEV O G ET AL: "Geminal systems. 27. Asymmetric nitrogen. 43. Aminomethylation of diaziridines by methylenediames, alkoxymethyl- and bis(alkoxymethyl)amines", DOKLADY AKADEMII NAUK SSSR <MOSKVA> = COMPTES RENDUS DE L'ACADÉMIE DES SCIENCES DE L'URSS, AKADEMIJA NAUK SSSR <MOSKVA, RU, vol. 284, no. 4, 1 January 1985 (1985-01-01), pages 872 - 876, XP009171020, ISSN: 0002-3264 *
SHUSTOV G V ET AL: "Asymmetric nitrogen. 60. Acylation as an access to optically-active 1,3,3-trisubstituted diaziridines", IZVESTIA AKADEMII NAUK SSSR. SERIA HIMICESKAA, INSTITUT ORGANICHESKOI KHIMII IM. N. D. ZELINSKOGO ROSSIISKOI AKADEMII, RU, no. 8, 1 January 1988 (1988-01-01), pages 1862 - 1868, XP009171032, ISSN: 0002-3353 *
SKRUPSKAYA, T. V. ET AL: "Complexes of .alpha., .omega.-bis(3,3-dialkyldiaziridin-1-yl)alkanes and their bis(2-arylcarbamoyl) derivatives with cadmium and nickel salts", RUSSIAN CHEMICAL BULLETIN , 57(1), 56-62 CODEN: RCBUEY; ISSN: 1066-5285, 2008, XP002701579 *
SOMOGYI, LASZLO: "On the structure of the products of rearrangement of some 3,3-disubstituted 1,2-dibenzoyldiaziridines", CHEMISCHE BERICHTE , 119(10), 2963-5 CODEN: CHBEAM; ISSN: 0009-2940, 1986, XP002701578 *

Also Published As

Publication number Publication date
JP2015512874A (en) 2015-04-30
WO2013121334A2 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
JO3146B1 (en) Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
MX2014004479A (en) Novel oxazine derivatives and their use in the treatment of disease.
WO2014070991A3 (en) Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
MX2015008957A (en) Fluoro-[1,3]oxazines as bace1 inhibitors.
SI2875011T1 (en) 5-ht3 receptor antagonists
WO2014106238A8 (en) Heterocyclic compounds and methods of use thereof
MX2014014106A (en) 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease.
MX351305B (en) Mineralocorticoid receptor antagonists.
MX2013011591A (en) Methods and compositions for treating neurodegenerative diseases.
MX2013011589A (en) Methods and compositions for treating parkinson&#39;s disease.
MX2009010407A (en) Fluorinated derivatives of deferiprone.
UA113538C2 (en) FLUOROMETHYL-5,6-DIHYDRO-4H- $ 1,3] OXAZINES
BR112014001908A2 (en) substituted heterocyclic aza derivatives
WO2013188273A8 (en) Topical ophthalmological pharmaceutical composition containing axitinib
PH12014502541A1 (en) 5-amino [1,4] thiazines as bace 1 inhibitors
WO2013040227A3 (en) Therapeutic compounds
IN2015MN00002A (en)
WO2013188283A8 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
WO2013188268A8 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
TN2013000533A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
WO2014014794A3 (en) Mineralocorticoid receptor antagonists
TN2015000275A1 (en) 4-HYDROXY-2-METHYL-5- (PROPAN-2-YLIDENE) CYCLOHEX-3-ENECARBALDEHYDE FOR THE PREVENTION AND TREATMENT OF A COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASE
MX2013002956A (en) Arylosulfonamides for the treatment of cns diseases.
NZ707773A (en) Methods of treating liver diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13727347

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014557140

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 13727347

Country of ref document: EP

Kind code of ref document: A2